argatroban and melagatran share 3 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.375 means 38% of the combined target set is bound by both compounds. The IDF-weighted score of 0.337 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do argatroban and melagatran have in common?
argatroban and melagatran share 3 molecular targets with a Jaccard similarity of 38%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can argatroban and melagatran be combined?
argatroban and melagatran share 3 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: argatroban or melagatran?
In the BiohacksAI corpus: argatroban has 0 PubMed-indexed studies, melagatran has 0 studies.